Optimal use of anthracycline-free perioperative chemotherapy in HER2-positive breast cancer patients.
Int J Clin Oncol
; 24(7): 807-814, 2019 Jul.
Article
in En
| MEDLINE
| ID: mdl-30810890
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Receptor, ErbB-2
/
Anthracyclines
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Int J Clin Oncol
Journal subject:
NEOPLASIAS
Year:
2019
Document type:
Article
Affiliation country:
Japan
Country of publication:
Japan